AAAAAA

   
Results: 1-10 |
Results: 10
Incidence, cost, and outcomes of bleeding and chemotherapy dose modification among solid tumor patients with chemotherapy-induced thrombocytopenia
Authors: Elting, LS Rubenstein, EB Martin, CG Kurtin, D Rodriguez, S Laiho, E Kanesan, K Cantor, SB Benjamin, RS
Citation: Ls. Elting et al., Incidence, cost, and outcomes of bleeding and chemotherapy dose modification among solid tumor patients with chemotherapy-induced thrombocytopenia, J CL ONCOL, 19(4), 2001, pp. 1137-1146
Colony stimulating factors in patients with fever and neutropenia
Authors: Rubenstein, EB
Citation: Eb. Rubenstein, Colony stimulating factors in patients with fever and neutropenia, INT J ANT A, 16(2), 2000, pp. 117-121
Identifying risk factors for imminent death in cancer patients with acute dyspnea
Authors: Escalante, CP Martin, CG Elting, LS Price, KJ Manzullo, EF Weiser, MA Harle, TS Cantor, SB Rubenstein, EB
Citation: Cp. Escalante et al., Identifying risk factors for imminent death in cancer patients with acute dyspnea, J PAIN SYMP, 20(5), 2000, pp. 318-325
Time to clinical response: An outcome of antibiotic therapy of febrile neutropenia with implications for quality and cost of care
Authors: Elting, LS Rubenstein, EB Rolston, K Cantor, SB Martin, CG Kurtin, D Rodriguez, S Lam, T Kanesan, K Bodey, G
Citation: Ls. Elting et al., Time to clinical response: An outcome of antibiotic therapy of febrile neutropenia with implications for quality and cost of care, J CL ONCOL, 18(21), 2000, pp. 3699-3706
The Multinational Association for Supportive Care in Cancer risk index: A multinational scoring system for identifying low-risk febrile neutropenic cancer patients
Authors: Klastersky, J Paesmans, M Rubenstein, EB Boyer, M Elting, L Feld, R Gallagher, J Herrstedt, J Rapoport, B Rolston, K Talcott, J
Citation: J. Klastersky et al., The Multinational Association for Supportive Care in Cancer risk index: A multinational scoring system for identifying low-risk febrile neutropenic cancer patients, J CL ONCOL, 18(16), 2000, pp. 3038-3051
Oral antibiotics for febrile patients with neutropenia due to cancer chemotherapy
Authors: Rubenstein, EB Rolston, KVI Kim, YJ
Citation: Eb. Rubenstein et al., Oral antibiotics for febrile patients with neutropenia due to cancer chemotherapy, N ENG J MED, 342(1), 2000, pp. 56-56
Influence of data display formats on decisions to stop clinical trials - Reply
Authors: Elting, LS Martin, CG Rubenstein, EB
Citation: Ls. Elting et al., Influence of data display formats on decisions to stop clinical trials - Reply, BR MED J, 319(7216), 1999, pp. 1070-1070
Influence of data display formats on physician investigators' decisions tostop clinical trials: prospective trial with repeated measures
Authors: Elting, LS Martin, CG Cantor, SB Rubenstein, EB
Citation: Ls. Elting et al., Influence of data display formats on physician investigators' decisions tostop clinical trials: prospective trial with repeated measures, BR MED J, 318(7197), 1999, pp. 1527-1531
Outpatient management of neutropenic fever: Antibiotics, growth factors orboth?
Authors: Rubenstein, EB Elting, LS Sun, CC Rolston, KVI
Citation: Eb. Rubenstein et al., Outpatient management of neutropenic fever: Antibiotics, growth factors orboth?, CLINICAL APPLICATIONS OF CYTOKINES AND GROWTH FACTORS, 1999, pp. 159-177
Mississippi mud in the 1990s - Risks and outcomes of vancomycin-associatedtoxicity in general oncology practice
Authors: Elting, LS Rubenstein, EB Kurtin, D Rolston, KVI Fangtang, J Martin, CG Raad, II Whimbey, EE Manzullo, E Bodey, GP
Citation: Ls. Elting et al., Mississippi mud in the 1990s - Risks and outcomes of vancomycin-associatedtoxicity in general oncology practice, CANCER, 83(12), 1998, pp. 2597-2607
Risultati: 1-10 |